Asymmetric Ionizable Cationic Lipid for RNA Delivery
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 12 of these applications claim priority to application 14/546,105, filed Nov 18, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,365,610 | Asymmetric Ionizable Cationic Lipid for RNA Delivery In force · Medium confidence UsedRemaining | Arcturus Therapeutics, Inc. | In force | Medium confidence | ||
| US 9,580,711 | Lipid Particles with Asymmetric Cationic Lipids for RNA Delivery In force · Medium confidence | Arcturus Therapeutics, Inc. | In force | Medium confidence | ||
| US 9,670,152 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 9,850,202 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 9,896,413 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 9,951,002 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 10,399,937 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 10,556,861 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 10,781,169 | Method of Synthesis of an Ionizable Cationic Lipid In force · High confidence | Arcturus Therapeutics, Inc. | In force | High confidence | ||
| US 9,567,296 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | Arcturus Therapeutic, Inc. | In force | High confidence | ||
| 6 more records in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16, including 1 expired.
12 of these are in force and held by Arcturus Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.